Takeda

Takeda Wins First FDA Approval for Ultra-Rare Blood Clotting Disease
BioSpace
Fri, 11/10/23 - 10:12 am
Takeda
FDA
ADAMTS13
Adzynma
cogenital thrombocytopenic purpura
Takeda Wins FDA Approval for Fruquintinib in Certain Colorectal Cancer Patients
BioSpace
Thu, 11/9/23 - 09:48 am
Takeda
fruquintinib
FDA
colorectal cancer
Tricks and Treats as Biopharma’s Q3 Earnings Season Gets Underway
BioSpace
Sun, 10/29/23 - 08:53 pm
earnings
Bristol Myers Squibb
Takeda
Novartis
Sanofi
Merck
Novartis claims ex-staffer jumped to Takeda with 'thousands' of sensitive files
Fierce Pharma
Thu, 10/26/23 - 10:52 pm
Novartis
Takeda
trade secrets
Takeda Reports $770M Write-Down, Cuts Profit Forecast by 71% for FY2023
BioSpace
Thu, 10/26/23 - 10:47 pm
Takeda
earnings
Takeda’s stem cell treatment Alofisel flunks phase 3 trial in Crohn's complication
Fierce Pharma
Thu, 10/19/23 - 10:07 am
Takeda
Crohn's Disease
Alofisel
clinical trials
stem cells
Takeda ponies up €130M to settle tax linked to distant AbbVie-Shire breakup fee
Fierce Pharma
Wed, 10/18/23 - 07:37 pm
Takeda
AbbVie
Shire
M&A
legal
Takeda to Withdraw Oncology Drug Exkivity from U.S. Market
Managed Healthcare Executive
Tue, 10/3/23 - 10:34 am
Takeda
Exkivity
clinical trials
non-small cell lung cancer
Path for BrainStorm ALS Treatment Remains Rocky, Hope for Others on Horizon
BioSpace
Sun, 10/1/23 - 01:05 pm
FDA
BrainStorm Cell Therapeutics
NurOwn
Seelos Therapeutics
Takeda
Clene
Takeda’s Entyvio receives FDA approval for subcutaneous administration
Pharmaceutical Technology
Thu, 09/28/23 - 11:46 pm
Takeda
Entyvio
ulcerative colitis
FDA
AcuraStem and Takeda Partner to Revolutionize ALS Treatment
Best Stocks
Mon, 09/25/23 - 07:40 pm
Takeda
AcuraStem
ALS
AS-202
Takeda settles antitrust lawsuit over gout drug Colcrys after trial kicked off
Fierce Pharma
Thu, 09/21/23 - 11:51 am
Takeda
generics
gout
Colcrys
antitrust
Roche scores—again—in hemophilia drug patent case against Takeda
Fierce Pharma
Thu, 09/21/23 - 11:47 am
Roche
Takeda
patents
legal
Genentech
Baxalta
hemophilia
AbbVie in line for hefty payout after Takeda breached supply contract on Lupron
Fierce Pharma
Thu, 09/7/23 - 10:25 am
AbbVie
Takeda
legal
Lupron
Fresh off $4B deal, Nimbus gears up for ‘third chapter’ with new fundraise
BioPharma Dive
Wed, 09/6/23 - 10:08 am
Nimbus Therapeutics
Takeda
funding
cancer
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
patent cliff
patents
Takeda
Vyvanse
Pfizer
Eraxis
JNJ
Stelara
Merck
Isentress
Eiger Pharmaceuticals
Zokinvy
Astellas
Myrbetriq
Novartis
Entresto
Amgen
Otzela
Takeda, Denali drop Alzheimer's asset after phase 1 peak reveals 'narrow therapeutic window'
Fierce Biotech
Wed, 08/9/23 - 11:56 am
Takeda
Denali Therapeutics
Alzheimer's disease
clinical trials
FDA Clears Taiho’s Lonsurf in Metastatic Colorectal Cancer Ahead of Takeda, Hutchmed
BioSpace
Thu, 08/3/23 - 10:23 am
Taiho Oncology
Lonsurf
colorectal cancer
FDA
Takeda
Hutchmed
Filings signal: Despite Covid losses, pharma earnings are promising
Clinical Trials Arena
Wed, 08/2/23 - 11:32 am
Takeda
AstraZeneca
Roche
earnings
COVID-19
Takeda reports data from Phase II narcolepsy type 1 therapy trial
Clinical Trials Arena
Thu, 07/27/23 - 10:16 am
Takeda
TAK-994
narcolepsy
clinical trials

Pages